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Abstract
Metallohydrolases catalyse some of the most important reactions in biology
and are targets for numerous chemotherapeutic agents designed to combat
bacterial infectivity, antibiotic resistance, HIV infectivity, tumour growth,
angiogenesis and immune disorders. Rational design of inhibitors of these
enzymes with chemotherapeutic potential relies on detailed knowledge of the
catalytic mechanism. The roles of the catalytic transition ions in these
enzymes have long been assumed to include the activation and delivery of a
nucleophilic hydroxy moiety. In the present study, catalytic intermediates in
the hydrolysis of L-leucyl-L-leucyl-L-leucine by Vibrio proteolyticus
aminopeptidase were characterized in spectrokinetic and structural studies.
Rapid-freeze-quench EPR studies of reaction products of L-leucyl-L-leucyl-Lleucine and Co(II)-substituted aminopeptidase, and comparison of the EPR
data with those from structurally characterized complexes of aminopeptidase
with inhibitors, indicated the formation of a catalytically competent postMichaelis pre-transition state intermediate with a structure analogous to that
of the inhibited complex with bestatin. The X-ray crystal structure of an
aminopeptidase–L-leucyl-L-leucyl-L-leucine complex was also analogous to
that of the bestatin complex. In these structures, no water/hydroxy group
was observed bound to the essential metal ion. However, a water/hydroxy
group was clearly identified that was bound to the metal-ligating oxygen atom
of Glu152. This water/hydroxy group is proposed as a candidate for the active
nucleophile in a novel metallohydrolase mechanism that shares features of
the catalytic mechanisms of aspartic proteases and of B2 metallo-βlactamases. Preliminary studies on site-directed variants are consistent with
the proposal. Other features of the structure suggest roles for the dinuclear
centre in geometrically and electrophilically activating the substrate.
Keywords: aminopeptidase, cobalt, EPR, metallohydrolase, Vibrio
proteolyticus, zinc
Abbreviations: BuBA, 1-butaneboronic acid; LL, L-leucyl-L-leucine; LLL, Lleucyl-L-leucyl-L-leucine; LPA, L-leucine phosphonic acid; LPNA, L-leucine-pnitroanilide; PSMA, prostate-specific membrane antigen; RFQ, rapid-freezequench; VpAP, aminopeptidase from Vibrio proteolyticus
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Introduction
The aminopeptidase from the bacterium Vibrio proteolyticus
(VpAP) is one of the more intensively studied metalloaminopeptidases
[1,2]. Metalloaminopeptidases are key players in cellular targeting of
proteins and protein degradation [3,4], aging [5], cataract formation
[6], HIV infectivity [7], bacterial infectivity [8], angiogenesis [9,10]
and cancer [9,11]. VpAP itself is of significant biomedical interest on
two accounts. First, aminopeptidases that are almost identical with
VpAP and are secreted by pathogenic bacteria that include species of
Vibrio, Aeromonas, Streptomyces and Clostridium have been shown to
be virulence factors in infectivity [8,12,13]. Aeromonad and noncholeraic vibrioid infections are an emerging public health concern,
giving rise to meningitis, osteomyelitis (bone infection), endocarditis
(infection of the lining and valves of the heart), wound infection and,
particularly, gastroenteritis [14–17]. Many of these bacteria have now
been found to have developed resistance to both traditional and ‘thirdgeneration’ antibiotics [18], but appear to be sensitive to
metalloaminopeptidase inhibitors [19]. VpAP inhibitors are therefore
possible candidates or templates for antibacterial drugs. A second
reason for interest in VpAP is the association of leucine
aminopeptidase activity with some cancers and the antitumour efficacy
of some potent VpAP inhibitors [7,20]. In addition, a THREADER [21]
analysis predicted that VpAP would have a strong (P=1) structural
homology with the carboxypeptidatic domain of the PSMA (prostatespecific membrane antigen); this has been confirmed following
crystallographic characterization of the PSMA ectodomain, and the
dimetallic active sites of these enzymes are superimposable [22]. Thus
mechanistic information on VpAP may well be relevant to PSMA and
other peptidases involved in cancer.
Native VpAP contains a (μ-aquo)(μ-carboxylato)-bridged dizinc
active site [23]. Zn(II) can be site-specifically replaced in either the
first (‘M1’) or second (‘M2’) site by many other transition ions, and
Co(II) furnishes monometallic [Co_(VpAP)], homodimetallic
[CoCo(VpAP)] and heterodimetallic [CoZn(VpAP)] and [ZnCo(VpAP)]
forms of the enzyme that, functionally, closely resemble the native
zinc-containing enzyme [24–26]. A combination of EPR spectroscopy
of Co(II)-containing VpAP and X-ray crystallography has been used to
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characterize the resting state, an inhibited species corresponding to a
putative Michaelis complex analogue, and a transition state analogue
complex of the enzyme [24,25,27–31]. Kinetic studies have provided
further mechanistic insight [26,32]. A detailed mechanism has been
proposed on the basis of these studies and was presented in graphic
form as Figure 10 in the original description by Petsko, Holz and coworkers [31]. The mechanism invokes (i) binding of substrate to a
substrate-recognition site distinct from the metal-containing active
site, (ii) binding of the carbonyl oxygen of the substrate to the M1
metal ion, with concomitant terminalization of the hitherto bridging
water molecule, providing an activated nucleophilic hydroxy group,
also bound to M1, (iii) nucleophilic attack of the M1-bound nucleophile
at the carbonyl carbon atom, forming a tetrahedral transition state,
and (iv) collapse of the transition state and proton transfer from
Glu151, yielding product and resting enzyme. Consistent with this
proposed mechanism, M1 is essential for catalysis. In contrast, the
effect of the presence of the second, M2, metal ion on catalytic
parameters is complex and is dependent on the nature of both M1 and
M2. EPR and crystallographic studies with the transition-state analogue
inhibitor LPA (L-leucine phosphonic acid) have characterized strong
interactions between LPA and the M2 metal ion, and M2 was proposed
to function to stabilize the transition state. Thus the primary function
of M1 has been described as providing the hydrolytic nucleophile for
attack on the M1-immobilized substrate, whereas that of M2 is to
stabilize the transition state.
In order to obtain further information on the hydrolytic
mechanism of VpAP, we carried out EPR spectrokinetic and X-ray
crystallographic studies of the enzyme using the bona fide substrate
LLL (L-leucyl-L-leucyl-L-leucine). While the proposed mechanism for
VpAP is consistent with a substantial body of experimental work, other
observations do not sit well with it. The complex substrate specificity
of VpAP and very closely related enzymes [33–37], the reaction
specificity, and the unusual and complex pattern of activation by
transition ions [26,38] are not explained by the proposed roles of M1
in the exposed active site of VpAP. The difficulty of reconciling these
and other observations with the proposed hydrolytic mechanism of
VpAP prompted a reexamination of the mechanism. For the first time,
direct structural information on the reaction of bona fide substrates
with VpAP was sought. In the present work, we describe the EPR
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spectra of catalytic intermediate species generated by RFQ (rapidfreeze-quench) techniques and the X-ray crystallographic structure of
VpAP in complex with the substrate LLL. Comparison of the EPR and
structural data with X-ray crystallographic structures and EPR data
from VpAP complexes with the inhibitors bestatin {ubenimex; N[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butyryl]-L-leucine} and
amastatin {(2S,3R)-3-amino-2-hydroxy-5-methylhexanoyl-Val-ValAsp-OH} indicate that the active site of the VpAP–LLL complex
characterized by X-ray crystallography corresponds to a catalytically
competent species in solution and observed in the RFQ–EPR studies.
On the basis of these data, a hitherto unconsidered novel mechanism
is proposed for the N-terminal hydrolysis of LLL by VpAP. The
proposed mechanism contains aspects of those of aspartic proteases
and class II aldolases, and of the mechanism recently proposed for the
class B2 metallo-β-lactamases on the basis of computational studies
[39]. This mechanism may represent a new paradigm for
metalloenzyme-catalysed hydrolysis in what could be considered a
distinct class of metallohydrolases, one in which the hydrolytically
active nucleophile is not delivered to the substrate by the metal ion(s).

Experimental
General chemicals
Except where stated, all reagents were of ACS or equivalent
quality. Milli-Q purified water (Millipore) was used throughout. Sea
salt, for culture of V. proteolyticus, was obtained from Sigma–Aldrich.
2-Methylbutane (isopentane) used for RFQ was certified ≥95% grade
from Fisher.

VpAP preparation
VpAP was purified from the supernatant of a 10 litre fermenter
(BioFlo) culture of V. proteolyticus (obtained from Professor R.C. Holz,
Department of Chemistry and Biochemistry, Utah State University,
Logan, UT, U.S.A.) as described in previous work [24]. VpAP was
characterized by electronic absorption spectrophotometry [40],
hydrolytic activity towards LPNA (L-leucine-p-nitroanilide) [26],
SDS/PAGE (12% gels) [41] and the Bio-Rad protein-binding dye assay
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[42] using well-characterized samples of purified VpAP as standards.
VpAP thus characterized was found to be >95% pure by SDS/PAGE
(12% gels), with specific activity indistinguishable from earlier
preparations. ApoVpAP was prepared by dialysis against 1,10phenanthroline for 72 h at 4 °C, followed by exhaustive dialysis
against Chelex™-treated buffer (50 mM Hepes, pH 7.2). [Co_(VpAP)]
was prepared by the addition of 1 equiv. of CoCl2, and [CoZn(VpAP)]
was prepared by incubation with 0.9 equiv. of CoCl2 for 10 min at
25 °C, followed by addition of 1.1 equiv. of ZnCl2.

Site-directed variants of VpAP
Recombinant wild-type and site-directed variants of VpAP were
generated using the expression system of Bzymek and Holz [32] and
Bzymek et al. [43]. Expression was induced in cell cultures exhibiting a
D600 of ∼0.9 with 1 mM IPTG (isopropyl β-D-thiogalactoside) and the
cultures were incubated further at 30 °C for 5.5 h with agitation in air
at 250 rev./min. Supernatant was clarified by centrifugation at 6500 g
for 10 min, and VpAP was precipitated with 560 g/l (NH4)2SO4. The
precipitate was pelleted at 10500 g for 1 h, redissolved in 50 mM
Hepes buffer, pH 7.5, dialysed against Hepes buffer, treated with
proteinase K and heat-treated for 2 h at 70 °C to denature
contaminating proteins and to process the translated polypeptide to
the mature enzyme form [43].

Kinetic studies
Hydrolysis of LPNA, LL (L-leucyl-L-leucine) and LLL was
monitored spectrophotometrically at 405 and 220 nm respectively
using an Applied Photophysics Model SX.18MV stopped-flow
instrument at 2–40 °C. LLL, LL or LPNA (2.5 mM final concentration)
was reacted with VpAP (27.5 μM final concentration) in 10 mM Tricine
buffer, pH 8.0. Apparent kinetic parameters K′m and k′cat for hydrolysis
of LLL to LL, LL to leucine, and LPNA to leucine and p-nitroanilide
under these conditions were estimated by fitting the appropriate part
of the progress curve that exhibited a linear relationship between
t−1{ln([S0]/[St])} and t−1([S0]−[St]) [44].
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RFQ–EPR studies
RFQ was carried out using the apparatus described in detail and
calibrated as in previous studies [45]. LLL (2.5 mM final concentration)
was reacted with 0.5 mM (final concentration) [CoZn(VpAP)] for
10 ms–1 s at 2 °C. A sample was thawed and refrozen and was
estimated to have been incubated for 1 min. [CoZn(VpAP)] has been
reported to exhibit a pH-dependent mixture of EPR signals, a rhombic
signal with 59Co hyperfine splitting and an axial signal devoid of
hyperfine structure [24,25]. It was observed that this form of VpAP
exhibited an essentially pure rhombic signal following incubation with
substrate (LPNA or LLL) and recovery by dialysis, and this form of the
enzyme was used as the starting material for RFQ–EPR studies. EPR
was performed using a Bruker E500 EleXsys spectrometer equipped
with an ER4116DM TE012/TE021 dual mode cavity operating at 9.63 GHz
in normal (Bstatic∥Bmicrowave) mode. Temperature control was effected
using an Oxford Instruments ESR900 helium flow cryostat and ITC502
temperature controller. Spectra were recorded at 9 K and 2 mW
microwave power, with 1.06 mT (10.6 G) field modulation at 100 kHz.
These conditions provided the best signal-to-noise ratio attainable
without detectable distortion of the spectra due to saturation,
relaxation broadening or rapid-passage effects. Individual EPRdetectable species were isolated by difference analysis of spectra of
resting enzyme and of reaction mixtures trapped at various times.
Basis spectra were confirmed as single species by computer simulation
(XSophe, Bruker Biospin [46]). Experimental spectra were modelled,
and contributions of individual species were quantified, by linear
combination and double integration respectively, of simulated basis
spectra. The reference sample for quantification was 0.5 mM Co(II) in
50 mM Hepes buffer, pH 7.2, and 50% glycerol, recorded under nonsaturating conditions (0.1 mW, 13 K), and the standard corrections for
gx(eff.)av., 1/T and (microwave power)½ were applied.

Crystallization of VpAP
VpAP was crystallized using the sitting-drop method. VpAP
(0.5 mM) in 10 mM Tris buffer, pH 8.0, containing 10 mM KSCN and
400 mM NaCl was equilibrated with 100 mM Tris buffer, pH 8.0,
containing 100 mM KSCN and 4.5 M NaCl; Tris was found to be an
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essential component. Crystals thus obtained underwent successive
transfer and incubation in 100 mM Hepes buffer, pH 8.0, containing
100 mM KSCN and 4.5 M NaCl, in order to remove Tris bound at the
active site [47]. A single microcrystalline speck of LLL was added, and
the crystallization plate was incubated at 23 °C for 16 h before data
collection.

X-ray crystallography
Paratone-N (Hampton Research) was used as a cryoprotectant.
The diffraction data were collected at −160 °C on a Rigaku R-AXIS
IV++, using Crystal Clear software. One crystal was used to collect the
entire set of data. An oscillation step size of 0.5° was used to collect
5.5 min exposures. Data were processed, and unit cell parameters
were determined with HKL2000 [48]. Since the aminopeptidase crystal
soaked in LLL was isomorphous with that of aminopeptidase bound to
BuBA (1-butaneboronic acid), the phases from that structure (PDB
code 1CP6 [29]) were used to solve the structure by molecular
replacement using AMoRe [49]. Model building was performed with the
interactive three-dimensional graphic program, Turbo-Frodo (version
OpenGL). The structure was manually inspected with electron density
maps with 2Fobs−Fcalc and Fobs−Fcalc coefficients. Structures were refined
using iterative cycles of energy minimization using the program
package CNS1.1 [50], alternating with manual map-fitting and model
rebuilding. Progress of the refinement was confirmed by the steady
decrease in both the Rcrystal and Rfree values. Water molecules were
added to the model using the WATERPICK protocol from CNS1.1.
Procheck was used to check Ramachandran (Φ, ψ) values [51].

Results
Kinetic studies
As prepared VpAP, and VpAP redissolved from crystalline
material, was found to be active towards both LPNA and LLL. A linear
relationship between ln(k′cat) and 1/T was observed for the hydrolysis
of LPNA by VpAP between 6 and 65 °C; the activation energy, Ea, was
estimated as 66 kJ·mol−1 and apparent kinetic constants for LPNA were
K′m (LPNA)=16 μM (6 °C) and 29 μM (25 °C), and k′cat (LPNA)=13 s−1
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(6 °C) and 82 s−1 (25 °C). These data extrapolated to a turnover time
of 83 ms at 2 °C. Apparent kinetic constants for LLL and LL, K′m
(LLL)=15 μM (6 °C) and 28 μM (25 °C), k′cat (LLL)=1.7 s−1 (6 °C) and
7 s−1 (25 °C), K′m (LL)=48 μM (6 °C) and 90 μM (25 °C), and k′cat
(LL)=0.3 s−1 (6 °C) and 2.6 s−1 (25 °C), indicated similar
thermodynamics for these substrates, although with slightly higher
values for Ea and, consequently, for the enthalpy of hydrolysis of these
substrates. Extrapolated turnover times for LLL and LL at 2 °C were
estimated as 380 ms and 3.6 s respectively. Recombinant wild-type
VpAP exhibited k′cat (LPNA)=10±3 s−1 (25 °C). Of the site-directed
variants E152D, E152T, E152S and E152Y, E152D preparations
exhibited 30–90% of the specific activity of wild-type VpAP, whereas
the others exhibited no activity under the assay conditions used (<5%
of wild-type activity). Control preparations from non-transfected cells
and from non-induced cultures of wild-type and E151D expression
systems did not exhibit any detectable activity towards LPNA.

RFQ–EPR studies
EPR spectra of resting [CoZn(VpAP)] and VpAP reacted with LLL
for 10 ms, 20 ms, 1 s and 1 min are shown as traces A–E in Figures 1
and and22 (Figure 2 shows the 59Co hyperfine structure expanded).
The spectrum of VpAP before reaction consisted of a single species and
was simulated as a rhombic signal with spin Hamiltonian parameters
S=3/2, MS=|±½〉, gx,y=2.57, gz=2.24, D≫gβBS (where D≫gβBS,
spectra are insensitive to D; D=50 cm−1 was used throughout),
E/D=0.21 and AyI=7/2(59Co)=8.1×10−3 cm−1. This EPR species is termed
the ‘resting’ species, even where observed in samples other than
resting enzyme. Upon reaction with LLL, clear changes in the spectrum
were observed and two new species (traces F and G in Figure 1) were
isolated from the experimental spectra of Figure 1, traces A, B and C.
The spectrum of traces F in Figure 1, termed here the ‘LLL-axial’
signal, was very broad, no hyperfine structure was resolved, and the
high-field gz feature was not resolved. The LLL-axial signal was
consistent with the approximate spin Hamiltonian parameters
gx,y∼2.28 and E/D∼0 (the parameters used for simulation were S=3/2,
MS=|±½〉, gx,y=2.28, gz=2.20, D=50 cm−1 and E/D=0.05). The
second species isolated by difference is shown as traces G in Figure 1
and is termed the ‘LLL-rhombic’ species; simulation returned the spin
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Hamiltonian parameters S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50,
D≫gβBS (50 cm−1), E/D=0.29 and AyI=7/2(59Co)=8.4×10−3 cm−1. Using
linear combinations of the three basis spectra, the resting, LLL-axial
and LLL-rhombic signals, the experimental spectra were reconstructed
as shown in Figures 1 and and2,2, and the proportions of each of the
basis spectra used in the simulations of the experimental spectra are
shown in Figure 3. Because the spectra contain both very broad and
very sharp features, least-squares iterative fitting is not an appropriate
fitting tool. The relative proportions of the resting and LLL-rhombic
species were judged both by the overall fit to the spectrum (Figure 1)
and by the fit of the complex hyperfine pattern at 700–1300 G (Figure
2), and changes in the values for the contributions of the resting and
LLL-rhombic of more than 10% of those used for the simulations
produced computed spectra that clearly did not match the
experimental data. The simulations were relatively insensitive,
however, to the inclusion of the LLL-axial species. Subtraction of
traces A from traces B (Figure 1) clearly showed that the LLL-axial
signal was present in trace B and integration of the simulation of the
difference spectrum indicated that it accounted for ∼10% of the spin
density of the EPR signal after 10 ms. It is unclear whether an axial
component is present in the spectrum of the resting enzyme or
whether some residual contribution of an axial signal is present at
20 ms and beyond, but it is clear that the intensity of the LLL-axial
signal increases up to 10 ms and diminishes thereafter. An interesting
observation was that the spin Hamiltonian parameters of the much
more well-defined LLL-rhombic species were very similar to those
reported for the EPR signal observed upon the addition of the
antitumour agent bestatin to [CoZn(VpAP)] [31] and, particularly,
almost indistinguishable from those obtained [S=3/2, MS=|±½〉,
gx,y=2.55, gz=2.40, D≫gβBS (50 cm−1), E/D=0.28 and
AyI=7/2(59Co)=8.3×10−3 cm−1] from simulation of the signal elicited by
the addition of amastatin to VpAP (Figure 4).
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Figure 1: EPR spectra of VpAP upon reaction with LLL
Traces A–E show the experimental EPR signals (upper traces), and computer
simulations thereof (lower traces), from resting [CoZn(VpAP)] (traces A), and VpAP
upon reaction with LLL at 2 °C for 10 ms (traces B), 20 ms (traces C), 1 s (traces D)
and 1 min (trace E). The experimental traces F and G were generated by difference
and each is overlaid with a computer simulation; traces F are the LLL-axial EPR signal
and traces G are the LLL-rhombic signal. The proportions of individual species, the
resting, LLL-axial and LLL-rhombic, used for the simulations are indicated in Figure 3,
and the spin Hamiltonian parameters for each are: resting, S=3/2, MS=|±½〉,
gx,y=2.57, gz=2.24, D≫gβBS (50 cm−1), E/D=0.21 and AyI=7/2(59Co)=8.1×10−3 cm−1;
LLL-axial, S=3/2, MS=|±½〉, gx,y=2.28, gz=2.20, D≫gβBS (50 cm−1) and E/D=0.05;
LLL-rhombic, S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50, D≫gβBS (50 cm−1), E/D=0.29
and AyI=7/2(59Co)=8.4×10−3 cm−1.
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Figure 2: 59Co hyperfine structure in the EPR spectra of VpAP upon reaction
with LLL
Expanded region of the EPR spectra of resting [CoZn(VpAP)] (traces A), and of VpAP
upon reaction with LLL at 2 °C for 10 ms (traces B), 20 ms (traces C) and 1 s (traces
D) and 1 min (traces E); the upper traces of A–F are the experimental data and the
lower traces are computer simulations. Trace F are of the LLL-rhombic species. The
proportions of individual species, the resting, LLL-axial and LLL-rhombic, used for the
simulations are indicated in Figure 3, and the spin Hamiltonian parameters for each
are given in the legend to Figure 1.
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Figure 3: Quantitative analysis of the EPR spectra of VpAP upon reaction with
LLL
Fractional intensities of the three EPR-detected species, the resting (●), LLL-axial (■)
and LLL-rhombic (▲), of VpAP at rest and upon reaction with LLL for 10 ms, 20 ms,
1 s and 1 min.
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Figure 4: EPR spectra of complexes of [CoZn(VpAP)] with LLL and amastatin
Traces A and C are EPR spectra of the LLL-rhombic complex of [CoZn(VpAP)] with LLL
(trace A) and of [CoZn(VpAP)] with amastatin (trace C). Traces B and D are computer
simulations of A and C respectively. Trace B was generated using the spin Hamiltonian
parameters S=3/2, MS=|±½〉, gx,y=2.56, gz=2.50, D≫gβBS (50 cm−1), E/D=0.29 and
AyI=7/2(59Co)=8.4×10−3 cm−1. Parameters for trace D were S=3/2, MS=|±½〉,
gx,y=2.55, gz=2.40, D≫gβBS (50 cm−1), E/D=0.28 and AyI=7/2(59Co)=8.3×10−3 cm−1.

X-ray crystallography
Crystals of VpAP soaked with LLL were hexagonal, with a space
group of P6122, as with other crystals of VpAP, and with unit cell
parameters closest to those of the VpAP–BuBA complex (Table 1). The
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X-ray crystal structure of LLL-soaked VpAP was determined to a
resolution of 2.0 Å (1 Å=0.1 nm) and the crystallographic data
collection and refinement statistics are given in Table 1. The protein
fold was found to be very similar to that of the native enzyme (PDB
code 1AMP [28]) and Cα superimposition gave an RMSD (root mean
square deviation) of 0.3 Å. Careful examination of omit maps and Bfactors suggested that the electron density may be best described as
representing a mixture of species, including LLL and LL bound at the
active site (Figure 5). Additional possible contributions may arise from
binding of LL and leucine in the S1, S1′ and S2′ sites; leucine is a poor,
purely competitive, inhibitor of VpAP, and LL is also an inhibitor of LLL
hydrolysis, although the mechanism is less clear. The main indicator of
the possibility of multiple species is the poor occupancy and/or high Bfactors for the side chains of Leu295 when refining assuming 100% LLL
bound. Additional refinements were carried out with leucine, LL, LA
(Leu-Ala) and LAL (Leu-Ala-Leu). In each case, the backbone structure
and the positions of the atoms of the P1-leucine, that is bound to the
active-site metals, are superimposable to well within the resolution of
the structure. A detailed examination of the structure of VpAP–LLL
revealed a number of very interesting features, some of which are
paralleled in the structures of inhibited complexes of VpAP: (i) in a
significant proportion of the sample, LLL is bound to both metal ions in
the active site and is intact; similarly, intact LL is also observed bound
in a manner entirely analogous to LLL (Figures 5 and and6);6); (ii) the
N-terminal carbonyl appears to be trigonal planar (sp2) indicating that
the LLL and LL complexes represent pre-transition state complexes;
(iii) LLL is bound with the side chain of P1-leucine apparently cis to P1′leucine (P1 denotes the N-terminal residue and P1′, P2′…Pn′ denote
subsequent residues of substrates; S1, S1′…Sn′ are the complementary
enzyme subsites [52]); (iv) the N-terminal carbonyl of LLL (and LL)
provides a μ-bridging oxygen atom that binds both metal ions, distinct
from the terminal binding of the substrate analogue inhibitor BuBA
(PDB code 1CP6 [29]) and from the more complex bridge found with
the transition state analogue inhibitor LPA (PDB code 1FT7 [30]), but
analogous to that seen with bestatin (PDB code 1TXR [31]); (v) the
M2 Zn(II) ion is also bound to the P1 amide nitrogen atom, forming a
ring structure that includes M2 and is similar to that observed with
LPA; (vi) there is no evidence for a water- or hydroxy-derived oxygen
bound to M1 or bridging M1 and M2; (vii) the side chain of Glu151, a
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residue implicated in proton delivery [32], appears to be cis to that of
Glu152, which provides an oxygen ligand to Zn1; (viii) there is a water
molecule hydrogen-bonded to the Zn(II)-binding oxygen atom, OE1, of
Glu152 [rO(water)−OE1(Glu152)=2.7 Å; rO(water)−Zn1=3.9 Å], analogous to that
observed at 2.9 Å from Glu152 OE1 in the structure with bestatin. OE1
of Glu151 is hydrogen-bonded (2.8 Å) to the amide group of the P1′leucine of LLL (or LL). It should be noted that, in the cases of P1leucine and P1′-leucine of LLL, and of Glu151 and Glu152 respectively,
the apparent cis configuration of the side chains is not due to a cis
peptide bond; this is evident in the case of LLL by examination along
the peptide bond of the structure. Rather, rotation around the ψ1
carbonyl-C–Cα bond of P1-leucine of LLL, and the analogous C–Cα ψ
bond of Glu151, is responsible. Unlike in the case of a genuine cis pair,
the appropriate residues fall into the additionally allowed category in
the Ramachandran plot rather than the generously allowed category;
we refer herein to such pairs of residues as adopting a ‘torqued-ψ’
configuration. Other features of this structure include the retention of
the cis configuration, seen in the native structure, of Asp118 and the
adjacent metal-bridging residue Asp117. Asp118 was one of two residues
in the generously allowed region of the Ramachandran plot, the other
being the substrate-binding hydrophobic pocket residue Met180. A
water molecule is observed at 2.4 Å from the OD1 oxygen atom of
Asp118. The final significant difference between the native and LLLbound structures is the conformation of the side chain of His105; in the
VpAP–LLL complex, this appears to fold over to form a ‘cap’ over the
side chain of the P2′-leucine of LLL, although no direct contact of His105
to LLL is made.
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Figure 5: Active-site structure of crystalline VpAP soaked in LLL
Labels identify the two Zn(II) ions and the VpAP residues His97, Asp117, Glu151, Glu152,
Asp179 and His256 of VpAP. The ligand is shown as an overlay of refined positions for
leucine (black), LL (dark grey) and LLL (light grey) and the darkness reflects the
occupancies.

Figure 6: Schematic diagram of the active site in the VpAP–LLL complex
Interatomic distances are shown in Å.
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Parameter

Value

Unit cell parameters
a (Å)

108.4

b (Å)

108.4

c (Å)

96.8

α, β, γ (°)

90, 90, 120

Collection and refinement parameters
Total number of reflections

524877

Unique reflections

23236

Space group

P6122

Resolution range (Å)

50.0–2.0

Last shell (Å)

2.07–2.00

Rsym

0.087

Overall completeness (%)

96.2

Last shell completeness (%)

78.3

Rcryst

0.206

Rfree

0.247

Ramachandran plot
Most favoured (%)

84.9

Additional allowed (%)

14.3

Generously allowed (%)

0.8 (Asp118, Met180)

<I/σI>

12.3

Table 1: Unit cell, symmetry and refinement parameters from crystallographic analysis of the VpAP–LLL complex (PDB code 2IQ6)

Discussion
RFQ–EPR is one of the few techniques that allow interrogation of
catalytic intermediates in enzymatic reactions. In the present study,
two intermediates have been shown by RFQ–EPR to be catalytically
competent and one, the LLL-rhombic species, has been well
characterized in terms of detailed spin Hamiltonian parameters. These
parameters indicate a high degree of electronic structural similarity to
the inhibited complexes of VpAP with bestatin and amastatin;
analogous structural elements for these species are predicted. In
particular, from both the EPR parameters of the LLL-rhombic species
itself and by analogy with the EPR and structures of the bestatin and
amastatin complexes of VpAP, the LLL-rhombic species is likely to
involve multiple ligands to the dinuclear metal centre, including a
metal-bridging oxygen, and does not accommodate an M1-bound
water/hydroxy nucleophile candidate.
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The crystal structure of the VpAP–LLL complex is the first
example of a structure of a leucine aminopeptidase complex with a
bona fide substrate. This structure is highly analogous to that of the
bestatin complex and the spectrokinetic RFQ–EPR data provide very
strong evidence that the structure of the active site in the
crystallographically characterized VpAP–LLL complex corresponds to
the kinetically competent LLL-rhombic catalytic intermediate species in
solution. Thus the crystallographic data provide high-resolution
structural information on a species that has been determined to be a
catalytically competent reaction intermediate in solution.
The crystal structure of the VpAP–LLL complex is extremely
interesting in a number of respects. Most strikingly, the structure
shows that LLL, or its primary product LL, is bound at the active site
forming a pre-transition state complex, but that there is no water or
hydroxy group bound to Zn1. LLL/LL provides one ligand, the μbridging carbonyl oxygen atom, to Zn1. Thus the co-ordination
number of Zn1 in the VpAP–LLL complex and in the resting enzyme is
the same. As the complex is a pre-transition state complex, formation
of the transition state requires nucleophilic attack by a hydroxy group
on the sp2-hybridized carbonyl carbon atom to form a tetrahedral
intermediate. In the previously proposed mechanism [29,30], the
nucleophilic hydroxy group was proposed to arise as a result of
terminalization on to Zn1 of a hitherto μ-bridging water or hydroxy
group. This Zn1-bound hydroxy group, activated by the Lewis acidity
of the Zn(II) ion, was then proposed to attack the substrate, also
bound to Zn1. However, whereas there is evidence in a related
methionyl aminopeptidase for a metal ion bound simultaneously to a
substrate analogue and a nucleophilic hydroxy group [53], there is no
such evidence for VpAP. The structure of the VpAP complex with the
substrate analogue BuBA shows that the oxygen that was presumed to
be that of the active nucleophile is weakly associated with the boron
atom of BuBA (rB−O=2.4 Å), but is completely dissociated from the
Zn(II) ions. In other crystal structures of VpAP complexes, with
bestatin and with LPA, there is also no M1-bound water molecule, but
there is a water molecule hydrogen-bonded to OE2 of Glu152 in the LPA
complex and to OE1 of Glu152 in the bestatin complex. The possible
catalytic significance of this water molecule has been hitherto
overlooked. The observation that there is no M1-bound water
molecule, but that there is a water molecule hydrogen-bonded to
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Glu152 OE1 in the VpAP–LLL complex, however, takes on mechanistic
significance if this species corresponds to a kinetically competent
catalytic intermediate in solution. The perhaps startling implication is
that the nucleophilic hydroxy group is activated and delivered to the
substrate not from the catalytically essential M1 metal ion, but from
either Glu152 or Asp118. Glu152 is the most likely candidate, particularly
given the inductive effect on Lewis acidity by virtue of also binding
Zn(II), and initial work on site-directed variants has shown the
catalytic importance of a carboxy-containing amino acid at position
152; a fuller characterization of Glu152 and Asp118 substitution variants
is warranted. The delivery of the nucleophile by a carboxy group is a
mechanistic aspect that is analogous to nucleophile activation by
aspartate carboxy side chains in the aspartic proteases. A recent
computational study led Guo and co-workers to propose that the
nucleophile is not delivered by the metal ion in the class B2 metallo-βlactamases, but, rather, by an aspartate residue [39]; this mechanism
has distinct energetic benefits, and roles of the metal ion include
electrophilic activation of substrate and stabilization of the leaving
group. Activation of substrate by active-site metal ions, rather than
nucleophile delivery, is a feature of the mechanism of class II
aldolases [54].
The proposal that the active nucleophile in VpAP-catalysed
hydrolysis is delivered not by a metal ion but by an active-site amino
acid is supported by a wealth of circumstantial evidence. A number of
observations are not well explained by the earlier proposed
mechanism, but are much more consistent with the new one. First,
VpAP exhibits substrate and reaction specificity, yet the active site is
very exposed to the solvent. Active sites of the type found in VpAP are
widely distributed among metallohydrolases, and a role in activating a
nucleophilic hydroxy group would be unlikely to confer either reaction
or substrate specificity. In VpAP, there is a hydrophobic patch adjacent
to the active site and this probably plays a role in substrate recognition
and specificity. However, with an exposed active site and an adjacent
extended hydrophobic patch, it would be expected that VpAP would
exhibit more stringent substrate specificity for larger substrates. In
fact, precisely the opposite is observed. The substrate specificity of
VpAP is most stringent for amino acid amides and amino acid pnitroanilides, efficiently hydrolysing only the leucine, isoleucine, valine,
methionine and phenylalanine derivatives. Substrate specificity is
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progressively less stringent for dipeptides and tripeptides, and only Nterminal aspartate, glutamate or cysteine are absolutely resistant to
hydrolysis in some larger peptides [36,37]. The key to understanding
the substrate specificity may be in appreciating the significance of the
finding that the P1- and P1′-leucine residues in the VpAP–LLL complex
are in a torqued-ψ configuration. This configuration is stabilized by the
interaction of the P1-leucine amino nitrogen with Zn2, and the
proximity of the P1 and P1′ side chains results in sterically induced
strain in the peptide bond. The relevance of this to catalysis is
highlighted by the high enthalpy of hydrolysis by VpAP, indicative of
conformational change. It is proposed here that the role of the metal
ions is therefore to act in concert with the hydrophobic patch to induce
the P1-P1′ torqued-ψ conformation change and stabilize the consequent
pre-transition state complex, weakening the scissile bond for
hydrolysis. Furthermore, binding to the metal ions electrophilically
activates the carbonyl carbon atom for nucleophilic attack. A torquedψ conformation is of little consequence for amino acid amides and pnitroanilides, and only the most favourable bulky hydrophobic
substrates are hydrolysed efficiently. Dipeptides are the smallest
substrates that can be geometrically activated via an enzyme-induced
torqued-ψ conformation. This higher energy conformation can be
stabilized further by interaction of larger substrates with the
hydrophobic patch, particularly those with hydrophobic P1′, P2′ etc.
residues; the phenomenon is reflected in the more efficient and less Nterminal-specific hydrolysis of peptides with hydrophobic P1′, P2′ and
P3′ residues [35,37].
Other observations perhaps further the contention that the role
of the metal centre, and M1 in particular, is not to activate and deliver
the nucleophile to the substrate. First, the pH-dependence of kcat
indicated that the free base form of an enzyme functional group with
pKa of ∼5.3 is required for hydrolysis of bound substrate [55]. This
suggests that the nucleophile is either derived from an aspartyl or
glutamyl carboxy group; more specifically, work on thermolysin has
suggested a concerted ‘inductive’ effect of a Glu-COO−-H2O-Zn(II)
structure in deprotonation of the carboxylate hydroxy group [56] and
therefore supports the hypothesis that the nucleophile is bound to the
same carboxy group oxygen, OE1 of Glu152, that is bound to Zn1 in the
VpAP–LLL complex. A second observation on VpAP that is not wellexplained by the earlier proposed mechanism is the complex pattern of
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activation of apoVpAP by transition metal ions. VpAP can be activated
with Zn(II), Co(II), Ni(II) and Cu(II), and the degree of activation of
the enzyme is dependent both upon the chemical identity of the metal
ions added and their order of addition, but not with Fe(II) or Mn(II)
[26,38]. The activation observed is not predictable on the basis of the
Lewis acidity of M1. For instance, [ZnCu(VpAP)] is as active as the
monometallic [Zn_(VpAP)] and is 80% as active as the homodimetallic
[ZnZn(VpAP)], whereas [Cu_(VpAP)] and [CuCu(VpAP)] are 5–6-fold
more active than [ZnZn(VpAP)]; [CuZn(VpAP)], on the other hand, is
two orders of magnitude more active than [ZnZn(VpAP)], and Ni(II)
elicits an activation profile analogous to that of Cu(II). The ability of
Cu(II) at the M1 site to activate VpAP, but not the related methionyl
aminopeptidase has been proposed to indicate that specificity is
dependent upon the co-ordination geometry of the M1 ion rather than
Lewis acidity [57]. The pronounced hyperactivity of [CuZn(VpAP)] over
[CuCu(VpAP)] indicated that the precise structure of the dinuclear site
is important; Cu2 in [CuCu(VpAP)] is not bound in the same site as Zn
in [CuZn(VpAP)]. The apparent requirement for nucleophile activation
with a pKa of ∼5.3 and the sensitivity of VpAP activity to the active-site
geometry are entirely consistent with a Glu152-derived nucleophile and
a role for the metal ions in substrate binding and activation rather than
of nucleophile activation. The torqued-ψ arrangement of Glu151 and
Glu152, and the role of Glu151 in proton transfer to the substrate [32],
provide further circumstantial support for the role of Glu152. The
observation that Asp117 and Asp118, and Glu151 and Glu152, are in cis and
torqued-ψ configurations respectively, was made in the original report
of the crystal structure of VpAP, and the general phenomenon that
non-proline cis amino acid pairs are generally involved in catalysis was
noted and discussed [28].
The new proposal, that the nucleophile in VpAP-catalysed
hydrolysis is not delivered by the metal ion, is consistent with all the
earlier reported data on VpAP and with the crystal structure described
herein, and it better explains other phenomena observed with VpAP.
This circumstantial evidence supports the new mechanism and
therefore the contention that the crystallographically characterized
active site in the VpAP–LLL complex corresponds to a genuine catalytic
intermediate. Experimental evidence for this contention is, however,
very desirable and would considerably strengthen the case for the new
mechanism. EPR studies supply this crucial evidence. Co(II) in the M1
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position of [CoZn(VpAP)] exhibits a rhombic EPR signal with resolved
hyperfine structure and, along with electronic absorption
spectrophotometry, these data indicate a five-co-ordinate site with a
relatively constrained and distorted geometry that includes a μbridging hydroxy group as a ligand to Co(II) [1,25,26]. Upon reaction
of [CoZn(VpAP)] with LLL under reaction conditions where the turnover
time is 380 ms, two new EPR species are detected, with significant
yields, within 10 ms. The first, the LLL-axial species, is indicative of a
six-co-ordinate Co(II) species with axial electronic symmetry and a
free water or hydroxy group ligand that is responsible for the
microheterogeneous structure of the Co(II) ions, reflected in the very
broad EPR signal [1]. This species accounts for approx. 10% of the
enzyme molecules and rapidly diminishes thereafter; it is therefore
short-lived. The second species, the LLL-rhombic species, is a five-coordinate species that is clearly distinct, both by observation and from
the spin Hamiltonian parameters, from the resting species. The very
narrow linewidths indicate that the co-ordination sphere consists of
‘rigid’ ligands with very little geometrical heterogeneity among the
population and argues strongly against co-ordinated water or hydroxy
group. Furthermore, this signal is very similar to the signals elicited by
amastatin and bestatin. The LLL-rhombic species accounts for 23% of
the enzyme molecules during the pre-steady-state phase of the first
turnover and diminishes to 11% by the third turnover. The high presteady-state concentrations of this species and the lower
concentrations as conditions approach the steady state are
characteristic of a relatively long-lived, but nevertheless catalytically
competent, intermediate that is formed after the LLL-axial species.
Thus EPR indicates that, upon reaction of the five-co-ordinate, hydroxy
group-bearing Co(II) ion in [CoZn(VpAP)] with LLL, the six-co-ordinate
LLL-axial species, bearing an unconstrained water or hydroxy group, is
first formed. This is presumably due to substrate binding via the
carbonyl oxygen. However, rather than this step being followed by
nucleophilic attack, a subsequent five-co-ordinate intermediate species
devoid of a free water/hydroxy group ligand, the LLL-rhombic, is
formed instead. Thus, consistent with the new mechanism, RFQ–EPR
identifies two kinetically competent catalytic intermediates: the first
formed by addition of substrate and the second by subsequent
dissociation of a water or hydroxy group.
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A central question is whether either of the EPR-identified
intermediates correspond to the crystallographically characterized
active site in VpAP–LLL. The structure of the bestatin and amastatin
complexes of VpAP is well-characterized, and the active site in these
complexes is very similar indeed to that of the VpAP–LLL complex
described herein, including a ligand carbonyl-derived μ-oxygen bridge,
an LLL-derived ring structure based on M2, the lack of an M1-bound
candidate for the nucleophile and the presence of a water molecule
hydrogen-bonded to OE1 of Glu152. It is therefore most striking that
this structural similarity is paralleled by the congruency of the EPR
signals of the bestatin and amastatin species with that of the LLLrhombic signal observed in RFQ–EPR experiments on VpAP with LLL. It
is also remarkable that the details of the EPR spectrum of the LLLrhombic species are entirely consistent with the structure of the VpAP–
LLL complex. The likely conclusion, then, is that the
crystallographically characterized active site of VpAP–LLL corresponds
to a kinetically competent catalytic intermediate, the LLL-rhombic
species, of the reaction of VpAP with LLL. These data provide very solid
support for the newly proposed mechanism.
A final phenomenon worthy of discussion is the low catalytic
activity of crystalline VpAP towards LLL. The crystallographic data
suggest that some activity had occurred, as LL is seen binding as a
substrate in an analogous manner to LLL. Furthermore, it is likely that
LL was partially hydrolysed and a number of species in which leucine is
bound to VpAP may be present. It is noteworthy that leucine is a pure
competitive inhibitor of VpAP and that, even at very high
concentrations, does not bind to Co(II) in cobalt-substituted VpAP.
Nevertheless, the high concentrations of leucine and LL may have
contributed to the poor activity of VpAP towards LLL, perhaps via an
entropic mechanism. Another possible reason for the low activity of
crystalline VpAP towards LLL (and LL) is that a conformational change
is required, as indicated by thermodynamic analyses, that is inhibited
in the crystalline state. The change in crystal appearance upon soaking
with LLL and the increased fragility of the crystals may suggest this. As
the protein fold is identical in VpAP–LLL and native (or Tris-complexed)
VpAP, this may suggest that a conformational change occurs after
substrate binding and reorientation. A second possibility is that while
the active site of VpAP–LLL corresponds to that in the reaction
intermediate, the protein fold differs in solution from that in the
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crystal. Finally, the altered conformation of the side-chain His105 may
or may not be significant. EPR spin-labelling experiments are
underway to address some of these issues.
In summary, very strong evidence is presented that the active
nucleophile in VpAP catalysis is not delivered by the metal centre. The
most likely candidate for the nucleophile is a water molecule
hydrogen-bonded to a carboxylate oxygen atom, itself a ligand to a
Zn(II) ion, of an active-site glutamate residue, Glu152. These findings
prompt a theoretical revisiting of the mechanisms of metallohydrolases
and have significant consequences for rational design of
therapeutically important inhibitors of these enzymes.
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